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To the Editor: 
Due to “stay at home” orders and risk of COVID-19, many parents now hesitate or fear 
seeking in-person consultation for their children.  This has led to reductions in emergency room 
visits and hospital admissions for other critical illnesses.  Additionally, health care providers 
have focused on COVID-19 management during the pandemic.  Because of Bayesian thinking, 
other diseases may be underdiagnosed or undergo delayed treatment. 
Because COVID-19 now leads as the probable diagnosis for first-line providers 
encountering febrile patients, the potential for missed or late diagnosis and treatment of 
Kawasaki disease in children is particularly concerning.1 Prompt diagnosis of KD and treatment 
with intravenous immunoglobulin (IVIG) prevents coronary artery aneurysms (CAA).2, 3 Without 
timely treatment CAAs could occur in up to 25% of children with Kawasaki disease.3   
We respectfully remind caregivers of the following principles for care of children with 
suspected or definite KD: 1) Keep a high suspicion for KD in all children with prolonged fever, 
but especially in those younger than 1 year; 2) Administer IVIG within 10 days, and ideally 
within 7 days, from onset of fever; 3) In the presence of ongoing systemic inflammation,  
children with Kawasaki disease presenting with greater than 10 days of fever and/or CAA may 
warrant IVIG treatment; 4) Continue to obtain recommended echocardiograms according to 
published guidelines3; 5) Watch for late manifestations of KD, review the clinical history, and 
seek pediatric cardiology consultation4, 5; 6) In the case of delayed diagnosis, refer to the 
American Heart Association management guidelines or contact an expert in Kawasaki disease3; 
7) Offer telemedicine services, remote echocardiogram, and direct to consumer visits that allow 
for nonverbal communication, when evaluating children with confirmed or suspected KD.6-8 
With this, we hope to avoid a future surge in prevalence of CAAs in patients due to missed or 
delayed diagnosis of KD. 
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